Gong-Qing Shen1, Domenico Girelli1, Lin Li1, Shaoqi Rao1, Stephen Archacki1, Oliviero Olivieri1, Nicola Martinelli1, Jeong Euy Park1, Qiuyun Chen1, Eric J Topol1, Qing K Wang2. 1. From the Department of Molecular Cardiology, Center for Cardiovascular Genetics, Lerner Research Institute, Cleveland Clinic, OH (G.-Q.S., L.L., S.R., S.A., Q.C., Q.K.W.); Department of Medicine, University of Verona, Verona, Italy (D.G., O.O., N.M.); Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea (J.E.P.); The Scripps Research Institute, Scripps Clinic, La Jolla, CA (E.J.T.); and Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Center for Human Genome Research, Huazhong University of Science and Technology, Wuhan, China (Q.K.W.). 2. From the Department of Molecular Cardiology, Center for Cardiovascular Genetics, Lerner Research Institute, Cleveland Clinic, OH (G.-Q.S., L.L., S.R., S.A., Q.C., Q.K.W.); Department of Medicine, University of Verona, Verona, Italy (D.G., O.O., N.M.); Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea (J.E.P.); The Scripps Research Institute, Scripps Clinic, La Jolla, CA (E.J.T.); and Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Center for Human Genome Research, Huazhong University of Science and Technology, Wuhan, China (Q.K.W.). wangq2@ccf.org qkwang@mail.hust.edu.cn.
Abstract
BACKGROUND: Many single-nucleotide polymorphisms have been associated with coronary artery disease (CAD)/myocardial infarction (MI) by genome-wide association studies, but the diagnostic value of these variants is limited. Functional single-nucleotide polymorphism R952Q in LRP8 is associated with familial and early-onset CAD/MI. The objective of this study is to test whether fine mapping and haplotype analysis for single-nucleotide polymorphisms flanking R952Q may identify a haplotype that may serve as a molecular diagnostic marker for familial and early-onset CAD/MI. METHODS AND RESULTS: Five single-nucleotide polymorphisms (rs7546246, rs2297660, rs3737983, R952Q, and rs5177) were genotyped and analyzed in GeneQuest (381 patients with familial, early-onset CAD and 183 patients with MI versus 560 controls) and the Italian population (248 patients with familial MI versus 308 controls). One novel risk haplotype, TACGC, was found only in patients with CAD and MI but not in controls. It was significantly associated with CAD (P=7.4×10(-7)) and MI (P=2.2×10(-9)) in GeneQuest. The finding was replicated in the Italian cohort (P=0.041). Sib-transmission disequilibrium test analysis showed a significant association between haplotype TACGC and CAD in GeneQuest II (P=0.039). Haplotype TACGC was not present in a South Korean population of 611 patients with CAD and 294 normal controls. TACGC/TACGC homozygotes tended to develop CAD/MI earlier and showed higher low-density lipoprotein cholesterol levels than heterozygotes (P<0.05). CONCLUSIONS: The rare haplotype TACGC in LRP8 confers a significant risk of familial, early-onset CAD/MI. Because the risk haplotype exists only in patients with familial and early-onset CAD/MI, we propose that it may be a molecular diagnostic marker for diagnosis of familial, early-onset CAD/MI in some white populations.
BACKGROUND: Many single-nucleotide polymorphisms have been associated with coronary artery disease (CAD)/myocardial infarction (MI) by genome-wide association studies, but the diagnostic value of these variants is limited. Functional single-nucleotide polymorphism R952Q in LRP8 is associated with familial and early-onset CAD/MI. The objective of this study is to test whether fine mapping and haplotype analysis for single-nucleotide polymorphisms flanking R952Q may identify a haplotype that may serve as a molecular diagnostic marker for familial and early-onset CAD/MI. METHODS AND RESULTS: Five single-nucleotide polymorphisms (rs7546246, rs2297660, rs3737983, R952Q, and rs5177) were genotyped and analyzed in GeneQuest (381 patients with familial, early-onset CAD and 183 patients with MI versus 560 controls) and the Italian population (248 patients with familial MI versus 308 controls). One novel risk haplotype, TACGC, was found only in patients with CAD and MI but not in controls. It was significantly associated with CAD (P=7.4×10(-7)) and MI (P=2.2×10(-9)) in GeneQuest. The finding was replicated in the Italian cohort (P=0.041). Sib-transmission disequilibrium test analysis showed a significant association between haplotype TACGC and CAD in GeneQuest II (P=0.039). Haplotype TACGC was not present in a South Korean population of 611 patients with CAD and 294 normal controls. TACGC/TACGC homozygotes tended to develop CAD/MI earlier and showed higher low-density lipoprotein cholesterol levels than heterozygotes (P<0.05). CONCLUSIONS: The rare haplotype TACGC in LRP8 confers a significant risk of familial, early-onset CAD/MI. Because the risk haplotype exists only in patients with familial and early-onset CAD/MI, we propose that it may be a molecular diagnostic marker for diagnosis of familial, early-onset CAD/MI in some white populations.
Authors: Gong-Qing Shen; Shaoqi Rao; Nicola Martinelli; Lin Li; Oliviero Olivieri; Roberto Corrocher; Kalil G Abdullah; Stanley L Hazen; Jonathan Smith; John Barnard; Edward F Plow; Domenico Girelli; Qing K Wang Journal: J Hum Genet Date: 2007-12-08 Impact factor: 3.172
Authors: Qing Wang; Shaoqi Rao; Gong-Qing Shen; Lin Li; David J Moliterno; L Kristin Newby; William J Rogers; Ruth Cannata; Erich Zirzow; Robert C Elston; Eric J Topol Journal: Am J Hum Genet Date: 2004-01-19 Impact factor: 11.025
Authors: Wolfgang Lieb; Tanja Zeller; Massimo Mangino; Anika Götz; Peter Braund; Juergen J Wenzel; Christian Horn; Carole Proust; Patrick Linsel-Nitschke; Philippe Amouyel; Petra Bruse; Dominique Arveiler; Inke R König; Jean Ferrières; Andreas Ziegler; Anthony J Balmforth; Alun Evans; Pierre Ducimetière; Francois Cambien; Christian Hengstenberg; Klaus Stark; Alistair S Hall; Heribert Schunkert; Stefan Blankenberg; Nilesh J Samani; Jeanette Erdmann; Laurence Tiret Journal: J Mol Med (Berl) Date: 2008-07-01 Impact factor: 4.599
Authors: Gong-Qing Shen; Lin Li; Domenico Girelli; Sara B Seidelmann; Shaoqi Rao; Chun Fan; Jeong Euy Park; Quansheng Xi; Jing Li; Ying Hu; Oliviero Olivieri; Kandice Marchant; John Barnard; Roberto Corrocher; Robert Elston; June Cassano; Susan Henderson; Stanley L Hazen; Edward F Plow; Eric J Topol; Qing K Wang Journal: Am J Hum Genet Date: 2007-08-31 Impact factor: 11.025
Authors: Fan Wang; Isabel Z Wang; Stephen Ellis; Stephen Archacki; John Barnard; Carlos Hubbard; Eric J Topol; Qiuyun Chen; Qing K Wang Journal: Ann Hum Genet Date: 2018-07-19 Impact factor: 1.670
Authors: Cavin K Ward-Caviness; Golareh Agha; Brian H Chen; Liliane Pfeiffer; Rory Wilson; Petra Wolf; Christian Gieger; Joel Schwartz; Pantel S Vokonas; Lifang Hou; Allan C Just; Stefania Bandinelli; Dena G Hernandez; Andrew B Singleton; Holger Prokisch; Thomas Meitinger; Gabi Kastenmüller; Luigi Ferrucci; Andrea A Baccarelli; Melanie Waldenberger; Annette Peters Journal: Clin Epigenetics Date: 2018-12-27 Impact factor: 6.551